The PD-1/PD-L1 pathway is a crucial self-tolerance pathway that tumor cells hijack to escape immune elimination and ICIs such as PD-(L)1 inhibitors target this pathway to enable immune mechanisms to target tumor cells [2]. This evidence concerns the gene CD274 and neoplasm.